✦ LIBER ✦

RNA Interference: Endogenous siRNAs Derived from Transposable Elements

✍ Scribed by Darren J. Obbard; David J. Finnegan

Book ID: 113561569
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 174 KB
Volume: 18
Category: Article
ISSN: 0960-9822
DOI: 10.1016/j.cub.2008.05.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term RNA interference from optimize

Long-term RNA interference from optimized siRNA expression constructs in adult mice

✍ Christine I. Wooddell; Cristopher V. Van Hout; Thomas Reppen; David L. Lewis; Ha 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 539 KB

Sequence-specific interference by small

Sequence-specific interference by small RNAs derived from adenovirus VAI RNA

✍ Masayuki Sano; Yoshio Kato; Kazunari Taira 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 412 KB

Endogenous siRNAs Derived from a Pair of

Endogenous siRNAs Derived from a Pair of Natural cis-Antisense Transcripts Regulate Salt Tolerance in Arabidopsis

✍ Omar Borsani; Jianhua Zhu; Paul E. Verslues; Ramanjulu Sunkar; Jian-Kang Zhu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 915 KB

Endogenous siRNAs Derived from a Pair of

Endogenous siRNAs Derived from a Pair of Natural cis-Antisense Transcripts Regulate Salt Tolerance in Arabidopsis

✍ Omar Borsani; Jianhua Zhu; Paul E. Verslues; Ramanjulu Sunkar; Jian-Kang Zhu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 915 KB

Control of vitellogenin genes expression

Control of vitellogenin genes expression by sequences derived from transposable elements in rainbow trout

✍ Anthony Bouter; Nicolas Buisine; Adélaïde Le Grand; Nathalie Mouchel; Franck Che 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 676 KB

[Advances in Delivery Science and Techno

[Advances in Delivery Science and Technology] RNA Interference from Biology to Therapeutics || Polymeric Micelles for siRNA Delivery

✍ Howard, Kenneth A. 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 816 KB

The enormous potential of siRNA as a therapeutic has led to an explosion of interest from the scientific community. There has been intense interest from Big Pharma to capitalise on this new technology but the fact remains that delivery is a key determinant in realizing the full clinical potential of